Brief: Otsuka and Lundbeck announce top-line results from two phase III clinical trials
Table: Otsuka -Q1 group results
Table: Otsuka -2016 parent results
Table: Otsuka -2016 group results
Table: Otsuka -9-MTH group results
Brief: Otsuka's 9-month group operating profit seen at about 28 bln yen - Nikkei
Table: Otsuka -6-MTH group results
Brief: Alkermes says U.S. District Court issued unambiguous opinion in favor of co, U.S. FDA - SEC filing
Brief: Otsuka Corp's group net profit apparently grew 9% for the January-June half of 2016 - Nikkei
New implant set to join fight against U.S. painkiller epidemic
Table: Otsuka -Q1 group results
Table: Otsuka -2015 parent results
Table: Otsuka -2015 group results
Table: Otsuka -9-MTH group results
Nexium, Advair led Medicare drug spending in 2013 -officials (updated)
Nexium, Advair led Medicare drug spending in 2013 - officials
Brief: EU agency backs Sanofi diabetes drug Toujeo plus medicines from Otsuka, Novartispproval in advanced non small cell lung cancer
GW Pharma's cannabis drug fails in cancer pain study (updated)
GW Pharma's cannabis drug fails in cancer pain study